Microbot Medical Inc. short interest in 2024
In 2024, Microbot Medical Inc.'s disclosed short interest ran from 0.27% of shares outstanding on 15 Feb 2024 to 6.12% on 31 Dec 2024, a change of +5.85 percentage points. The year's high was 6.12% on 31 Dec 2024 and its low 0.19% on 29 Feb 2024, averaging 2.16% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 5.76 days on 15 May 2024. Full history: Microbot Medical Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 0.27% (15 Feb 2024)
- End of year
- 6.12% (31 Dec 2024)
- Change
- +5.85 pp
- High
- 6.12% (31 Dec 2024)
- Low
- 0.19% (29 Feb 2024)
- Average
- 2.16%
- Highest days to cover
- 5.76 (15 May 2024)
- SEC filings marked
- 4
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Feb 2024 | 0.27% | 1.00 | |
| 29 Feb 2024 | 0.19% | 1.00 | |
| 28 Mar 2024 | 1.20% | 2.22 | 10-K filed |
| 15 Apr 2024 | 1.77% | 2.36 | |
| 30 Apr 2024 | 2.38% | 2.36 | |
| 15 May 2024 | 2.12% | 5.76 | 10-Q filed |
| 31 May 2024 | 2.04% | 3.92 | |
| 14 Jun 2024 | 2.60% | 1.00 | |
| 28 Jun 2024 | 2.11% | 1.94 | |
| 15 Jul 2024 | 1.25% | 1.00 | |
| 31 Jul 2024 | 1.33% | 1.00 | |
| 15 Aug 2024 | 1.07% | 1.29 | 10-Q filed |
| 30 Aug 2024 | 1.25% | 1.44 | |
| 13 Sep 2024 | 1.64% | 3.01 | |
| 30 Sep 2024 | 1.93% | 3.05 | |
| 15 Oct 2024 | 2.36% | 1.55 | |
| 31 Oct 2024 | 3.43% | 3.20 | |
| 15 Nov 2024 | 3.47% | 3.58 | 10-Q filed |
| 29 Nov 2024 | 3.43% | 4.74 | |
| 13 Dec 2024 | 3.41% | 2.53 | |
| 31 Dec 2024 | 6.12% | 1.09 |
See also: Microbot Medical Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.